Differential modulation of nucleus accumbens synapses.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 12091540)

Published in J Neurophysiol on July 01, 2002

Authors

James M Brundege1, John T Williams

Author Affiliations

1: The Vollum Institute, Oregon Health and Science University, Portland, Oregon 97201, USA.

Articles by these authors

Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci (2006) 2.80

Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron (2004) 2.20

mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci (2002) 1.81

GABA release from proopiomelanocortin neurons. J Neurosci (2004) 1.53

Differential activation and trafficking of micro-opioid receptors in brain slices. Mol Pharmacol (2008) 1.49

Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J Neurosci (2004) 1.47

Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J Neurosci (2005) 1.46

Two intracellular pathways mediate metabotropic glutamate receptor-induced Ca2+ mobilization in dopamine neurons. J Neurosci (2003) 1.44

Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons. J Neurosci (2011) 1.41

G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons. J Neurosci (2002) 1.35

Control of extracellular dopamine at dendrite and axon terminals. J Neurosci (2010) 1.33

Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures. J Neurosci (2006) 1.30

Morphine-Induced mu-opioid receptor desensitization. Mol Pharmacol (2005) 1.18

Recovery from mu-opioid receptor desensitization after chronic treatment with morphine and methadone. J Neurosci (2011) 1.17

Decreased vesicular somatodendritic dopamine stores in leptin-deficient mice. J Neurosci (2007) 1.15

Self-administration enhances excitatory synaptic transmission in the bed nucleus of the stria terminalis. Nat Neurosci (2005) 1.15

Chronic morphine treatment reduces recovery from opioid desensitization. J Neurosci (2004) 1.14

Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization. Mol Pharmacol (2008) 1.13

Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons. J Neurosci (2009) 1.13

The time course of dopamine transmission in the ventral tegmental area. J Neurosci (2009) 1.10

CRF facilitates calcium release from intracellular stores in midbrain dopamine neurons. Neuron (2008) 1.10

Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism. Proc Natl Acad Sci U S A (2003) 1.10

Noradrenergic inhibition of midbrain dopamine neurons. J Neurosci (2004) 1.08

The natural products parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma. Leuk Lymphoma (2011) 1.07

Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents. J Neurophysiol (2006) 1.07

CRF enhancement of GIRK channel-mediated transmission in dopamine neurons. Neuropsychopharmacology (2009) 1.07

Modulating neuromodulation by receptor membrane traffic in the endocytic pathway. Neuron (2012) 1.07

Long-term depression of a dopamine IPSC. J Neurosci (2007) 1.02

Morphine desensitization and cellular tolerance are distinguished in rat locus ceruleus neurons. Mol Pharmacol (2012) 1.00

Spontaneous inhibitory synaptic currents mediated by a G protein-coupled receptor. Neuron (2013) 1.00

Frequency-dependent synchrony in locus ceruleus: role of electrotonic coupling. Proc Natl Acad Sci U S A (2002) 0.96

Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure. J Neurosci (2013) 0.94

Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization. J Neurosci (2009) 0.93

Small-cell undifferentiated carcinoma of neuroendocrine type originating in the gallbladder. Curr Surg (2005) 0.91

Presynaptic regulation of dendrodendritic dopamine transmission. Eur J Neurosci (2007) 0.91

Loss of Mecp2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway. J Neurosci (2011) 0.90

Pre- and postsynaptic regulation of locus coeruleus neurons after chronic morphine treatment: a study of GIRK-knockout mice. Eur J Neurosci (2008) 0.88

Desensitization and trafficking of μ-opioid receptors in locus ceruleus neurons: modulation by kinases. Mol Pharmacol (2011) 0.86

Increase in adenosine sensitivity in the nucleus accumbens following chronic morphine treatment. J Neurophysiol (2002) 0.85

Activation of µ-opioid receptors and block of Kir3 potassium channels and NMDA receptor conductance by L- and D-methadone in rat locus coeruleus. Br J Pharmacol (2010) 0.83

A selective 5-HT1a receptor agonist improves respiration in a mouse model of Rett syndrome. J Appl Physiol (1985) (2013) 0.81

Caged naloxone reveals opioid signaling deactivation kinetics. Mol Pharmacol (2013) 0.80

Cocaine self-administration selectively decreases noradrenergic regulation of metabotropic glutamate receptor-mediated inhibition in dopamine neurons. J Neurosci (2004) 0.80

Does PKC activation increase the homologous desensitization of μ opioid receptors? Br J Pharmacol (2014) 0.79

Chronic morphine treatment alters endogenous opioid control of hippocampal mossy fiber synaptic transmission. J Neurophysiol (2002) 0.78

Mesoprefrontal dopamine neurons distinguish themselves. Neuron (2008) 0.76

Neuroscience: Promiscuous vesicles. Nature (2012) 0.75